Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells.

[1]  R. Bick,et al.  Thrombotic Thrombocytopenic Purpura: An Extended Editorial , 2008, Seminars in thrombosis and hemostasis.

[2]  D. Lynch,et al.  HIV‐1 upregulates Fas ligand expression in CD4+ T cells in vitro and in vivo : association with Fas‐mediated apoptosis and modulation by aurintricarboxylic acid , 1996, Immunology.

[3]  R. Holman,et al.  Increasing mortality from thrombotic thrombocytopenic purpura in the United States—analysis of national mortality data, 1968–1991 , 1995, American journal of hematology.

[4]  M. Leon,et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.

[5]  T. Miyawaki,et al.  Activation of the apoptotic Fas antigen-encoding gene upon influenza virus infection involving spontaneously produced beta-interferon. , 1995, Virology.

[6]  G. Rock,et al.  Late Relapses in Patients Successfully Treated for Thrombotic Thrombocytopenic Purpura , 1995, Annals of Internal Medicine.

[7]  L. Benítez-Bribiesca.  [Apoptosis in the pathogenesis and treatment of disease]. , 1995, Gaceta medica de Mexico.

[8]  C. Smith,et al.  Fas ligand mediates activation-induced cell death in human T lymphocytes , 1995, The Journal of experimental medicine.

[9]  N. Tandon,et al.  Anti‐CD36 antibodies in thrombotic thrombocytopenic purpura , 1994, British journal of haematology.

[10]  K. Schooley,et al.  Regulation of apoptosis and T cell activation by Fas-specific mAb. , 1994, International immunology.

[11]  J. Inazawa,et al.  Human Fas ligand: gene structure, chromosomal location and species specificity. , 1994, International immunology.

[12]  B. Stewart.  Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. , 1994, Journal of the National Cancer Institute.

[13]  Y. Fujimura,et al.  Inhibition by aurintricarboxylic acid of von Willebrand factor binding to platelet GPIb, platelet retention, and thrombus formation in vivo , 1994, American journal of hematology.

[14]  J. Moake,et al.  Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura. , 1994, Blood.

[15]  W. Harrington,et al.  Thrombotic microangiopathy and retroviral infections: A 13‐year experience , 1994, American journal of hematology.

[16]  J. Moake.  Haemolytic-uraemic syndrome: basic science. , 1994 .

[17]  B. Harmon,et al.  A flow cytometric study of cell death: Failure of some models to correlate with morphological assessment , 1994, Immunology and cell biology.

[18]  N. Chirmule,et al.  Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. , 1993, Blood.

[19]  D. Adams,et al.  Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells , 1993, The Journal of experimental medicine.

[20]  J. Pober,et al.  Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. , 1993, Journal of immunology.

[21]  A. Del Arco,et al.  Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus infection: demonstration of p24 antigen in endothelial cells. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  J. Sampol,et al.  Detection of Circulating Endothelial Cells in Thrombotic Thrombocytopenic Purpura , 1993, Thrombosis and Haemostasis.

[23]  J. Kelton,et al.  Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. , 1992, Blood.

[24]  L. Damon,et al.  Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. , 1992, Blood.

[25]  J Savill,et al.  Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. , 1992, The Journal of clinical investigation.

[26]  J. Laurence,et al.  Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V β expression , 1992, Nature.

[27]  M. Cushman,et al.  Inhibition of HIV-1 integration protein by aurintricarboxylic acid monomers, monomer analogs, and polymer fractions. , 1992, Biochemical and biophysical research communications.

[28]  S. Orrenius,et al.  Tumor necrosis factor alpha induces apoptosis in mammary adenocarcinoma cells by an increase in intranuclear free Ca2+ concentration and DNA fragmentation. , 1992, Cancer research.

[29]  T. Wick,et al.  Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. , 1992, Journal of immunology.

[30]  H. Niwano,et al.  Circulating thrombomodulin in thrombotic thrombocytopenic purpura , 1991, American journal of hematology.

[31]  Atsushi Hase,et al.  The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis , 1991, Cell.

[32]  D. Richman,et al.  Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. , 1991, The Journal of clinical investigation.

[33]  C. Prinz,et al.  Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: Models of de‐endothelialization and repair , 1991, Journal of cellular biochemistry.

[34]  W. Fiers,et al.  Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. , 1991, The American journal of pathology.

[35]  N. Yamamoto,et al.  Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[36]  E. Favaloro,et al.  Co‐expression of haemopoietic antigens on vascular endothelial cells: a detailed phenotypic analysis , 1990, British journal of haematology.

[37]  J. Laurence,et al.  Effect of tamoxifen on regulation of viral replication and human immunodeficiency virus (HIV) long terminal repeat-directed transcription in cells chronically infected with HIV-1. , 1990, Blood.

[38]  S. Orrenius,et al.  Calcium‐activated DNA fragmentation kills immature thymocytes , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  M. Ziff,et al.  Endothelial cell activation induced by tumor necrosis factor and lymphotoxin. , 1989, The American journal of pathology.

[40]  S. Karpatkin,et al.  Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection. , 1988, Annals of internal medicine.

[41]  J. Moake,et al.  LYTIC ANTI-ENDOTHELIAL CELL ANTIBODIES IN HAEMOLYTIC-URAEMIC SYNDROME , 1988, The Lancet.

[42]  E. Lian.  Pathogenesis of thrombotic thrombocytopenic purpura. , 1987, Seminars in hematology.

[43]  H. Kwaan.  Clinicopathologic features of thrombotic thrombocytopenic purpura. , 1987, Seminars in hematology.

[44]  G. Remuzzi,et al.  Prostacyclin in thrombotic microangiopathy. , 1987, Seminars in hematology.

[45]  E. Burns,et al.  Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. , 1982, Blood.

[46]  J. S. Clubb,et al.  Thrombotic thrombocytopenic purpura in four siblings. , 1975, The American journal of medicine.

[47]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[48]  K. Koretz,et al.  Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[49]  Z. Darżynkiewicz,et al.  Features of apoptotic cells measured by flow cytometry. , 1992, Cytometry.

[50]  P. Neame.  Immunologic and Other Factors in Thrombotic Thrombocytopenic Purpura (TTP) , 1980, Seminars in thrombosis and hemostasis.